Landing Medical

Landing Med is a medical technology company specializing in AI-driven early cancer detection, with a primary focus on cervical cancer screening. Founded in 2000 and headquartered in Wuhan, China, the company provides an end-to-end solution that integrates high-throughput digital pathology scanners with cloud-based artificial intelligence for automated cytology analysis. Their flagship products include the AI Cervical Cytology System and various digital pathology scanners designed to improve diagnostic precision and efficiency in laboratories. Landing Med has screened over 10 million women globally and operates an international cloud platform to facilitate remote diagnostics and large-scale screening programs in resource-limited settings.